{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:33:29Z","timestamp":1774614809796,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T00:00:00Z","timestamp":1415059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jaad.2014.08.048","type":"journal-article","created":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T21:41:23Z","timestamp":1415137283000},"page":"108-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["The adverse effect profile of oral azathioprine in pediatric atopic dermatitis, and recommendations for monitoring"],"prefix":"10.1016","volume":"72","author":[{"given":"Nicholas R.","family":"Fuggle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Bragoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjali","family":"Mahto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Glover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna E.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica A.","family":"Kinsler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2014.08.048_bib1","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1365-2133.2002.04989.x","article-title":"Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial","volume":"147","author":"Berth-Jones","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.08.048_bib2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(06)68340-2","article-title":"Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomized controlled trial","volume":"367","author":"Meggitt","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2014.08.048_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaci.2011.03.024","article-title":"A randomized trial of methotrexate versus azathioprine for severe atopic eczema","volume":"128","author":"Schram","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2014.08.048_bib4","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1046\/j.1365-2133.2002.04922.x","article-title":"A retrospective evaluation of azathioprine in severe childhood atopic eczema, using thiopurine methyltransferase levels to exclude patients at\u00a0high risk of myelosuppression","volume":"147","author":"Murphy","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.08.048_bib5","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1525-1470.2011.01488.x","article-title":"Systemic treatment of\u00a0pediatric atopic dermatitis with azathioprine and mycophenolate mofetil","volume":"28","author":"Waxweiler","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2014.08.048_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaad.2012.07.001","article-title":"Oral azathioprine for recalcitrant pediatric atopic dermatitis: clinical response and thiopurine monitoring","volume":"68","author":"Caufield","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.08.048_bib7","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1365-2230.2008.02832.x","article-title":"Further experience of using azathioprine in the treatment of severe atopic dermatitis","volume":"33","author":"Hughes","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2014.08.048_bib8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jaad.2005.07.059","article-title":"Azathioprine in dermatology: the past, the present, and the future","volume":"55","author":"Patel","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2014.08.048_bib9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/qjmed\/95.7.439","article-title":"Erythrocyte thiopurine methyl transferase assessment prior to azathioprine use in the UK","volume":"95","author":"Holme","year":"2002","journal-title":"Q J Med"},{"key":"10.1016\/j.jaad.2014.08.048_bib10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1525-1470.2003.20617.x","article-title":"Azathioprine as a treatment for severe atopic eczema in children with a partial thiopurine methyl transferase (TPMT) deficiency","volume":"20","author":"Murphy","year":"2003","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2014.08.048_bib11","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1365-2133.2011.10575.x","article-title":"Mohd Mustapa MF, Reynolds NJ, Wakelin S. British Association of Dermatologists' guidelines for the safe and effective prescribing of azathioprine 2011","volume":"165","author":"Meggitt","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.08.048_bib12","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1038\/sj.onc.1209372","article-title":"Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions","volume":"25","author":"Wang","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.jaad.2014.08.048_bib13","doi-asserted-by":"crossref","first-page":"d1417","DOI":"10.1136\/bmj.d1417","article-title":"Life threatening myelotoxicity secondary to azathioprine in a patient with atopic eczema and normal thiopurine methyltransferase activity","volume":"342","author":"Wee","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2014.08.048_bib14","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1001\/archdermatol.2011.79","article-title":"Off-label use of azathioprine in dermatology: a systematic review","volume":"147","author":"Schram","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2014.08.048_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/MEG.0b013e32834233a2","article-title":"Natural history of azathioprine-associated lymphopenia in inflammatory bowel disease patients: a prospective observational study","volume":"23","author":"Al Rifai","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jaad.2014.08.048_bib16","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/bjd.12196","article-title":"Eczema severity in preadolescent children and its relation to sex, filaggrin mutations, asthma, rhinitis, aggravating factors and topical treatment: a report from the BAMSE birth cohort","volume":"168","author":"Ballardini","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2014.08.048_bib17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2214.1998.00051.x","article-title":"Short stature at school entry\u2013an index of social deprivation? (The Wessex growth study)","volume":"24","author":"Voss","year":"1998","journal-title":"Child Care Health Dev"},{"key":"10.1016\/j.jaad.2014.08.048_bib18","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/adc.64.11.1566","article-title":"Growth in atopic eczema: a controlled study by questionnaire","volume":"64","author":"Pike","year":"1989","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jaad.2014.08.048_bib19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1079\/BJN20051503","article-title":"Evaluation of diet and growth in children with and without atopic eczema: follow-up study from birth to 4 years","volume":"94","author":"Laitinen","year":"2005","journal-title":"Br J Nutr"},{"key":"10.1016\/j.jaad.2014.08.048_bib20","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/adc.68.5.677","article-title":"Growth in atopic eczema","volume":"68","author":"Massarano","year":"1993","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jaad.2014.08.048_bib21","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1398-9995.2009.01987.x","article-title":"Neuropsychologic status at the age 4 years and atopy in a population-based birth cohort","volume":"64","author":"Julvez","year":"2009","journal-title":"Allergy"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962214019057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962214019057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:33:27Z","timestamp":1759271607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962214019057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0190962214019057"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2014.08.048","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The adverse effect profile of oral azathioprine in pediatric atopic dermatitis, and recommendations for monitoring","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2014.08.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Academy of Dermatology, Inc. Published by Mosby, Inc.","name":"copyright","label":"Copyright"}]}}